Unmet need identification
BostonGene identifies treatment gaps to empower pharmaceutical companies with strategic recommendations for drug repurposing and indication selection.
Disease settings selection
7,000
Anti-cancer agents in the fully annotated
BostonGene drug database, including approval
status, mechanism of action and more
BostonGene drug database, including approval
status, mechanism of action and more
BostonGene identifies areas with significant unmet medical needs by conducting an in-depth review of clinical guidelines, medical literature, treatment protocols and the proprietary drug database.
Effectiveness of the existing treatments
30,000
Annotated publications with survival data from completed clinical trials in the BostonGene database
BostonGene helps pinpoint areas where SOC treatments are less effective by comparing novel drug candidates with the SOC survival data using a proprietary database.
Assessment of the competing drug candidates
10,000
Ongoing clinical trials in the
BostonGene database
BostonGene database
BostonGene evaluates market potential by analyzing the landscape of competing drugs in a daily-updated, proprietary database of ongoing clinical trials.
